- $2.66bn
- $5.31bn
- $1.57bn
- 49
- 82
- 22
- 49
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 769 | 858 | 1,851 | 3,628 | 1,565 |
Cost of Revenue | |||||
Gross Profit | 581 | 613 | 1,568 | 2,820 | 876 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 535 | 696 | 1,303 | 1,393 | 1,339 |
Operating Profit | 234 | 162 | 548 | 2,235 | 227 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 125 | -61.6 | -230 | 1,402 | 247 |
Provision for Income Taxes | |||||
Net Income After Taxes | 96.9 | -52.4 | -242 | 1,141 | 212 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 96.9 | -52.4 | -242 | 1,141 | 211 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 74.1 | -83.4 | -259 | 1,141 | 212 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.566 | -0.385 | -0.13 | 4.25 | 0.764 |
Dividends per Share |